J Gastric Cancer.  2019 Jun;19(2):157-164. 10.5230/jgc.2019.19.e12.

Prospective Multicenter Feasibility Study of Laparoscopic Sentinel Basin Dissection after Endoscopic Submucosal Dissection for Early Gastric Cancer: SENORITA 2 Trial Protocol

• Eom BW
• Yoon HM
• Min JS
• Cho I
• Park JH
• Jung MR
• Hur H
• Kim YW
• Park YK
• Nam BH
• Ryu KW
• Sentinel Node Oriented Tailored Approach (SENORITA) Study Group

• KMID: 2449936
• DOI: http://doi.org/10.5230/jgc.2019.19.e12

Abstract

PURPOSE
Although standard radical gastrectomy is recommended after noncurative resection of endoscopic submucosal dissection (ESD) for early gastric cancer in most cases, residual tumor and lymph node metastasis have not been identified after surgery. The aim of this study is to evaluate the feasibility of sentinel node navigation surgery after noncurative ESD.
MATERIALS AND METHODS
This trial is an investigator-initiated, multicenter prospective phase II trial. Patients who underwent ESD for clinical stage T1N0M0 gastric cancer with noncurative resections were eligible. Qualified investigators who completed the prior phase III trial (SENORITA 1) are exclusively allowed to participate. In this study, 2 detection methods will be used: 1) intraoperative endoscopic submucosal injection of dual tracer, including radioisotope and indocyanine green (ICG) with sentinel basins detected using gamma-probe; 2) endoscopic injection of ICG, with sentinel basins detected using a fluorescence imaging system. Standard laparoscopic gastrectomy with lymphadenectomy will be performed. Sample size is calculated based on the inferior confidence interval of the detection rate of 95%, and the calculated accrual is 237 patients. The primary endpoint is detection rate, and the secondary endpoints are sensitivity and postoperative complications.
CONCLUSIONS
This study is expected to clarify the feasibility of laparoscopic sentinel basin dissection after noncurative ESD. If the feasibility is demonstrated, a multicenter phase III trial will be initiated to compare laparoscopic sentinel node navigation surgery versus laparoscopic standard gastrectomy in early gastric cancer after endoscopic resection. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03123042

Keyword

Gastric cancer; Sentinel lymph node; Endoscopic submucosal dissection

MeSH Terms

Feasibility Studies*
Gastrectomy
Humans
Indocyanine Green
Lymph Node Excision
Lymph Nodes
Neoplasm Metastasis
Neoplasm, Residual
Optical Imaging
Postoperative Complications
Prospective Studies*
Research Personnel
Sample Size
Stomach Neoplasms*
Indocyanine Green

Figure

• 

  Fig. 1 Study scheme of the SENORITA 2 trial.SENORITA = Sentinel Node Oriented Tailored Approach.

• 

  Fig. 2 First endoscopic injection of dual tracer around the ESD ulcer scar (A). Final endoscopic injection around the ESD ulcer scar. Elevated mucosa around the ESD scar by tracer injection is observed (B).ESD = endoscopic submucosal dissection.

• 

  Fig. 3 Intraoperative identification of sentinel basins. Green-stained basin after injection of dual tracer (A) and indocyanine green fluorescence imaging (B-D). Lymphatic vessels draining the tumor and sentinel node are visualized by green (B), blue (C), and bright fluorescence (D).

Reference

1. Wang Z, Dong ZY, Chen JQ, Liu JL. Diagnostic value of sentinel lymph node biopsy in gastric cancer: a meta-analysis. Ann Surg Oncol. 2012; 19:1541–1550. PMID: 22048632.

2. Kitagawa Y, Takeuchi H, Takagi Y, Natsugoe S, Terashima M, Murakami N, et al. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol. 2013; 31:3704–3710. PMID: 24019550.

3. Park JY, Kim YW, Ryu KW, Nam BH, Lee YJ, Jeong SH, et al. Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-a multicenter randomized phase III clinical trial (SENORITA trial) protocol. BMC Cancer. 2016; 16:340. PMID: 27246120.

4. Eom BW, Jung KW, Won YJ, Yang H, Kim YW. Trends in gastric cancer incidence according to the clinicopathological characteristics in Korea, 1999–2014. Cancer Res Treat. 2018; 50:1343–1350. PMID: 29361823.

5. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011; 14:113–123. PMID: 21573742.

6. Eom BW, Kim YI, Kim KH, Yoon HM, Cho SJ, Lee JY, et al. Survival benefit of additional surgery after noncurative endoscopic resection in patients with early gastric cancer. Gastrointest Endosc. 2017; 85:155–163.e3. PMID: 27460389.

7. Kim ER, Lee H, Min BH, Lee JH, Rhee PL, Kim JJ, et al. Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer. Br J Surg. 2015; 102:1394–1401. PMID: 26313295.

8. Ishii S, Yamashita K, Kato H, Nishizawa N, Ushiku H, Mieno H, et al. Predictive factors for lymph node metastasis in additional gastrectomy after endoscopic resection of cT1aN0 gastric cancer. Surg Today. 2016; 46:1031–1038. PMID: 26658717.

9. Toyokawa T, Ohira M, Tanaka H, Minamino H, Sakurai K, Nagami Y, et al. Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer. Surg Endosc. 2016; 30:2404–2414. PMID: 26463497.

10. Suzuki H, Oda I, Abe S, Sekiguchi M, Mori G, Nonaka S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016; 19:198–205. PMID: 25616808.

11. Lee YJ, Jeong SH, Hur H, Han SU, Min JS, An JY, et al. Prospective multicenter feasibility study of laparoscopic sentinel basin dissection for organ preserving surgery in gastric cancer: quality control study for surgical standardization prior to phase III trial. Medicine (Baltimore). 2015; 94:e1894. PMID: 26512607.

12. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009; 250:187–196. PMID: 19638912.

13. Ryu KW, Eom BW, Nam BH, Lee JH, Kook MC, Choi IJ, et al. Is the sentinel node biopsy clinically applicable for limited lymphadenectomy and modified gastric resection in gastric cancer? A meta-analysis of feasibility studies. J Surg Oncol. 2011; 104:578–584. PMID: 21695700.

14. Arigami T, Uenosono Y, Yanagita S, Matsushita D, Arima H, Hirata M, et al. Feasibility of sentinel node navigation surgery after noncurative endoscopic resection for early gastric cancer. J Gastroenterol Hepatol. 2013; 28:1343–1347. PMID: 23663136.

15. Mayanagi S, Takeuchi H, Kamiya S, Niihara M, Nakamura R, Takahashi T, et al. Suitability of sentinel node mapping as an index of metastasis in early gastric cancer following endoscopic resection. Ann Surg Oncol. 2014; 21:2987–2993. PMID: 24682720.

16. Can MF, Yagci G, Cetiner S. Sentinel lymph node biopsy for gastric cancer: Where do we stand? World J Gastrointest Surg. 2011; 3:131–137. PMID: 22007282.